HC Wainwright reiterated their buy rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $15.00 target price on the stock. A number of other research analysts have also recently issued reports on the stock. StockNews.com cut shares of Syros Pharmaceuticals […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 1,740,000 shares, an increase of 31.8% from the February 29th total of 1,320,000 shares. Approximately 9.6% of the shares of the stock are short sold. Based […]
Insider Selling: Syros Pharmaceuticals, Inc (NASDAQ:SYRS) Insider Sells $29,024 60 in Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.